Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
X Li, W Sun, X Ding, W Li, J Chen - Frontiers in Immunology, 2022 - frontiersin.org
Background The combination of immune checkpoint inhibitors (ICIs) and anti-angiogenic
agents has shown promising efficacy in unresectable hepatocellular carcinoma (HCC), but …
agents has shown promising efficacy in unresectable hepatocellular carcinoma (HCC), but …
A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features
R Sheng, Y Zhang, H Wang, W Zhang, K Jin, W Sun… - European …, 2024 - Springer
Objectives To establish a non-invasive diagnostic system for intrahepatic mass-forming
cholangiocarcinoma (IMCC) via decision tree analysis. Methods Totally 1008 patients with …
cholangiocarcinoma (IMCC) via decision tree analysis. Methods Totally 1008 patients with …
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors
ZX Zeng, JY Wu, JY Wu, YN Li, YK Fu, ZB Zhang… - Hepatology …, 2024 - Springer
Background and aims Transcatheter arterial chemoembolization combined with lenvatinib
and PD-1 inhibitors (triple therapy) exhibits promising efficacy for unresectable …
and PD-1 inhibitors (triple therapy) exhibits promising efficacy for unresectable …
Tumor radiomic features on pretreatment MRI to predict response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a multicenter study
B Xu, SY Dong, XL Bai, TQ Song, BH Zhang, LD Zhou… - Liver Cancer, 2023 - karger.com
Introduction: Lenvatinib plus an anti-PD-1 antibody has shown promising antitumor effects in
patients with advanced hepatocellular carcinoma (HCC), but with clinical benefit limited to a …
patients with advanced hepatocellular carcinoma (HCC), but with clinical benefit limited to a …
Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma
J Cheng, X Li, L Wang, F Chen, Y Li… - Journal of Magnetic …, 2024 - Wiley Online Library
Background Macrotrabecular‐massive hepatocellular carcinoma (MTM‐HCC) is highly
aggressive. Comparing the diagnosis ability of CT and gadoxetate disodium (Gd‐EOB …
aggressive. Comparing the diagnosis ability of CT and gadoxetate disodium (Gd‐EOB …
[HTML][HTML] Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular …
NQ Liao, ZJ Deng, W Wei, JH Lu, MJ Li, L Ma… - Computational and …, 2024 - Elsevier
Objectives Combination therapy of lenvatinib and immune checkpoint inhibitors (CLICI) has
emerged as a promising approach for managing unresectable hepatocellular carcinoma …
emerged as a promising approach for managing unresectable hepatocellular carcinoma …
The GRAPHS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with immunotherapy
Y Yang, L Li, Y Xu, J Ouyang, Y Zhou, F Ye… - La radiologia …, 2024 - Springer
Objectives To investigate MR features associated with prognosis of unresectable HCC
receiving immunotherapy and establish a MR feature-based scoring system to predict …
receiving immunotherapy and establish a MR feature-based scoring system to predict …
Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular …
Y Sheng, Q Wang, HF Liu, Q Wang… - British Journal of …, 2024 - academic.oup.com
Objectives To establish and verify a prognostic nomogram model for selecting in
unresectable hepatocellular carcinoma (uHCC) treated by transarterial chemoembolization …
unresectable hepatocellular carcinoma (uHCC) treated by transarterial chemoembolization …
What Imaging Modality Is More Effective in Predicting Early Recurrence of Hepatocellular Carcinoma after Hepatectomy Using Radiomics Analysis: CT or MRI or Both …
Q Wang, Y Sheng, Z Jiang, H Liu, H Lu, W Xing - Diagnostics, 2023 - mdpi.com
Background: It is of great importance to predict the early recurrence (ER) of hepatocellular
carcinoma (HCC) after hepatectomy using preoperative imaging modalities. Nevertheless …
carcinoma (HCC) after hepatectomy using preoperative imaging modalities. Nevertheless …
Evaluation of immune microenvironment in hepatocellular carcinoma: current advances in CT and MRI imaging techniques
S Chenyu, Z Chunxiang, L Lujie, T Mimi, W Jifei… - Chinese Journal of …, 2024 - Springer
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide
with a high mortality. Tumor immune microenvironment (TIM) plays an important role in the …
with a high mortality. Tumor immune microenvironment (TIM) plays an important role in the …